Yervoy (ipilimumab) - Ono Pharma, BMS
Keytruda (pembrolizumab) - Merck (MSD)
ACT 2001 - Norwegian Radium Hospital, Alden Cancer Therapy II, Haakon Ragde Foundation
https://www.sciencedirect.com//science/article/pii/S2666168320338428
 
Thomsen L.C.V.1; Honoré A.2; Almås B.2; Reisæter L.A.R.3; Førde K.2; Kristoffersen E.K.4; Kaada S.H.4; Melve G.K.4; Helle S.I.5; Kvalheim G.6; Azeem W.7; Olsen J.R.7; Halvorsen O.J.8; Akslen L.A.1; Bahn D.9; Pantel K.10; Riethdorf S.10; Ragde H.11; Gjertsen B.T.1; Øyan A.M.4; Kalland K.H.1; Beisland C.2
 
May 2, 2020
 
Next